[1]
A. Sonsuz, “Efficacy and Safety of Ombitasvir/Paritaprevir/ Ritonavir + Dasabuvir ± Ribavirin Combinations in Patients with Genotype 1 Hepatitis C and Inherited Bleeding Disorders”, Turkish Journal of Gastroenterology, vol. 33, no. 5, pp. 414–420, Jan. 2022.